Puma Biotechnology (PBYI) Prepaid Assets (2011 - 2026)
Puma Biotechnology (PBYI) posted Prepaid Assets of $3.4 million for Q1 2026, up 201.86% on a QoQ basis from $1.1 million in Q4 2025, and up 3374.49% year-over-year from $98000.0 in Q1 2025.
Puma Biotechnology (PBYI) Prepaid Assets (2011 - 2026) Analysis & Trends
Puma Biotechnology's Prepaid Assets history runs 16 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- Quarterly Prepaid Assets rose 3374.49% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (up 3374.49% YoY) and the FY2025 annual result came in at $1.1 million, up 1139.56% from the prior year.
- Prepaid Assets was $3.4 million for Q1 2026 at Puma Biotechnology, up from $1.1 million in the prior quarter.
- Across five years, Prepaid Assets topped out at $8.6 million in Q2 2022 and bottomed at $91000.0 in Q4 2024.
- A 5-year average of $1.8 million and a median of $1.4 million in 2023 frame the typical range for Prepaid Assets.
- Annual changes were most pronounced in 2024 — Prepaid Assets sank 93.51% — and 2026, when it soared 3374.49%.
- Puma Biotechnology's Prepaid Assets stood at $2.4 million in 2022, then plunged by 42.24% to $1.4 million in 2023, then plunged by 93.51% to $91000.0 in 2024, then surged by 1139.56% to $1.1 million in 2025, then jumped by 201.86% to $3.4 million in 2026.
- Business Quant data shows PBYI's Prepaid Assets at $3.4 million in Q1 2026, $1.1 million in Q4 2025, and $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Puma Biotechnology | 407.27 Mn | 368.99 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.41 Mn |
| Dec 31, 2025 | 1.13 Mn |
| Sep 30, 2025 | 3.83 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 98,000.00 |
| Dec 31, 2024 | 91,000.00 |
| Sep 30, 2024 | 236,000.00 |
| Jun 30, 2024 | 241,000.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 1.40 Mn |
| Sep 30, 2023 | 408,000.00 |
| Jun 30, 2023 | 1.44 Mn |
| Mar 31, 2023 | 1.71 Mn |
| Dec 31, 2022 | 2.43 Mn |
| Sep 30, 2022 | 589,000.00 |
| Jun 30, 2022 | 8.58 Mn |
| Mar 31, 2022 | 2.42 Mn |
| Dec 31, 2021 | 3.18 Mn |
| Sep 30, 2021 | 2.73 Mn |
| Jun 30, 2021 | 478,000.00 |